EADV 2023 Insights

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

EADV 2023 Insights

Videos

Playback speed

10 seconds

EADV 2023 Insights: Impact of Povorcitinib on DLQI and DLQI Subdomains in Patients with Hidradenitis Suppurativa: Results from a Randomized, Placebo-Controlled Phase 2 Study

By EADV 2023 Insights FEATURING Falk Bechara

118 views

October 16, 2023

0 Comments

Videos

17:47

EADV 2023 Insights

EADV 2023 Insights: Dermascopic Evaluation of Cutaneous Leishmaniasis

Feat. M. Al-Dhalimi

14:16

EADV 2023 Insights

EADV 2023 Insights: Clinical Pitfalls - What Not to Miss?

Feat. T. Duong

17:51

EADV 2023 Insights

EADV 2023 Insights: Diagnostic Benefits of New Non-Invasive Technolo…

Feat. L. Tognetti

12:33

EADV 2023 Insights

EADV 2023 Insights: Drug Survival of IL-23 p19 Inhibitors Compared t…

Feat. Z. Yiu

19:31

EADV 2023 Insights

EADV 2023 Insights: Ablative and Non-Ablative Lasers in Skin of Color

Feat. M. Sachdev

19:10

EADV 2023 Insights

EADV 2023 Insights: Interstitial Fluid Immunophenotyping of Early-St…

Feat. S. Wind

09:48

EADV 2023 Insights

EADV 2023 Insights: Screening for Inflammatory Bowel Disease in Hidr…

Feat. N. Kearney

06:09

EADV 2023 Insights

EADV 2023 Insights: Case Report of Epidermolysis Bullosa Acquisita i…

Feat. S. Zobiri

13:51

EADV 2023 Insights

EADV 2023 Insights: Ceramide-Based Skincare Provides Adjunctive Effi…

Feat. M. Li

31:32

EADV 2023 Insights

EADV 2023 Insights: Biological Markers in the Management of Cutaneou…

Feat. J. Cañueto

09:43

EADV 2023 Insights

EADV 2023 Insights: Relevant Biomarkers in Chronic Urticaria

Feat. P. Kolkhir

10:49

EADV 2023 Insights

EADV 2023 Insights: AD, PN, and CSU - Three Skin Diseases with a Com…

Feat. M. Ferrer

14:45

EADV 2023 Insights

EADV 2023 Insights: Emerging Therapies for Androgenetic Alopecia 2023

Feat. S. Vano

18:44

EADV 2023 Insights

EADV 2023 Insights: Severe Cutaneous Adverse Reactions in Childhood:…

Feat. M. Mockenhaupt

18:09

EADV 2023 Insights

EADV 2023 Insights: Contact Dermatitis and Ulcer Treatment

Feat. M. Czarnecka-Operacz

21:40

EADV 2023 Insights

EADV 2023 Insights: Neonatal Dermatologic Emergencies: What Should W…

Feat. N. Moftah

18:44

EADV 2023 Insights

EADV 2023 Insights: Fulfilling Great Expectations - Safety of Biolog…

Feat. J. Murase

17:17

EADV 2023 Insights

EADV 2023 Insights: Pediatric Hidradenitis Suppurativa

Feat. S. Garcovich

10:56

EADV 2023 Insights

Cutaneous Lupus Erythematosus

Feat. M. Gonçalo

14:05

EADV 2023 Insights

EADV 2023 Insights: Managing Nail Disorders Through Onychoscopy

Feat. F. Pampaloni

23:09

EADV 2023 Insights

EADV 2023 Insights: Generalized Pustular Psoriasis: Current and Futu…

Feat. M. Elsamahy

23:37

EADV 2023 Insights

EADV 2023 Insights: Inflammatory Disease of the Face

Feat. V. Torres

19:59

EADV 2023 Insights

EADV 2023 Insights: Pediatric Nail Disorders

Feat. M. Iorizzo

05:34

EADV 2023 Insights

EADV 2023 Insights: The Future of Sentinel Lymph Node Biopsies

Feat. S. Ribero

05:28

EADV 2023 Insights

EADV 2023 Insights: Non-Pharmacological Interventions for Eczema to …

Feat. H. Singleton

08:09

EADV 2023 Insights

EADV 2023 Insights: Insulin Resistance in Acanthosis Nigricans

Feat. S. Feldman

05:49

EADV 2023 Insights

EADV 2023 Insights: Devices and Innovations that Failed - What Do We…

Feat. K. Fritz

07:56

EADV 2023 Insights

EADV 2023 Insights: How to Increase the Duration of Botulinum Effect…

Feat. K. Fritz

07:56

EADV 2023 Insights

EADV 2023 Insights: Which Lasers for Which Scar

Feat. K. Fritz

11:43

EADV 2023 Insights

EADV 2023 Insights: Nail Disorders: Pearls for Medical and Surgical …

Feat. B. Piraccini

05:37

EADV 2023 Insights

EADV 2023 Insights: Baricitinib in Alopecia Areata: Tailoring Treatm…

Feat. B. Piraccini

20:28

EADV 2023 Insights

EADV 2023 Insights: Nail Changes: When to Suspect an Underlying Dise…

Feat. M. Starace

10:07

EADV 2023 Insights

EADV 2023 Insights: Skin Cancer - Limits of Office Based Surgery

Feat. M. Leventer

27:24

EADV 2023 Insights

EADV 2023 Insights: Infectious Granulomatous Skin Diseases

Feat. E. Laffitte

29:01

EADV 2023 Insights

EADV 2023 Insights: How to Avoid Mistreatment of Neoplastic Lesions

Feat. I. Zalaudek

14:25

EADV 2023 Insights

EADV 2023 Insights: Treating Cancer in the Elderly: Minimally Invasi…

Feat. P. Pasquali

17:32

EADV 2023 Insights

EADV 2023 Insights: Fungal Infections of the Scalp: Current Treatmen…

Feat. J. Mashiah

09:25

EADV 2023 Insights

EADV 2023 Insights: Managing Mild to Severe Rosacea

Feat. L. Stein Gold

12:24

EADV 2023 Insights

EADV 2023 Insights: Impact of Povorcitinib on DLQI and DLQI Subdomai…

Feat. F. Bechara

26:24

EADV 2023 Insights

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

Feat. G. Hofbauer

16:02

EADV 2023 Insights

EADV 2023 Insights: Understanding the Differences Between MOA and Ta…

Feat. L. Kircik